Explore Pharmaceutical Manufacturing (EMPC) is a strategic greenfield initiative established to reduce Ethiopia’s reliance on imported sterile intravenous (IV) fluids. The project will develop a state-of-the-art facility to manufacture high-quality, affordable large volume parenteral (LVP) solutions, including Normal Saline, Ringer’s Lactate, and Dextrose, with plans for future product expansion. The plant is designed to fully comply with WHO-GMP and EFDA regulatory standards.